nodes	percent_of_prediction	percent_of_DWPC	metapath
Rifabutin—HSP90B1—oviduct—ovarian cancer	0.0403	0.145	CbGeAlD
Rifabutin—HSP90AA1—oviduct—ovarian cancer	0.0295	0.106	CbGeAlD
Rifabutin—CYP3A4—Topotecan—ovarian cancer	0.0181	0.354	CbGbCtD
Rifabutin—HSP90B1—myometrium—ovarian cancer	0.0129	0.0464	CbGeAlD
Rifabutin—CYP3A4—Vinorelbine—ovarian cancer	0.0128	0.249	CbGbCtD
Rifabutin—HSP90B1—embryo—ovarian cancer	0.0124	0.0446	CbGeAlD
Rifabutin—HSP90B1—epithelium—ovarian cancer	0.0101	0.0364	CbGeAlD
Rifabutin—HSP90B1—uterine cervix—ovarian cancer	0.01	0.0361	CbGeAlD
Rifabutin—HSP90B1—decidua—ovarian cancer	0.00955	0.0344	CbGeAlD
Rifabutin—HSP90AA1—myometrium—ovarian cancer	0.00942	0.0339	CbGeAlD
Rifabutin—HSP90B1—endometrium—ovarian cancer	0.00907	0.0326	CbGeAlD
Rifabutin—HSP90AA1—embryo—ovarian cancer	0.00906	0.0326	CbGeAlD
Rifabutin—CYP3A4—Paclitaxel—ovarian cancer	0.00897	0.175	CbGbCtD
Rifabutin—HSP90B1—gonad—ovarian cancer	0.00841	0.0303	CbGeAlD
Rifabutin—HSP90B1—uterus—ovarian cancer	0.00836	0.0301	CbGeAlD
Rifabutin—HSP90B1—female reproductive system—ovarian cancer	0.00751	0.027	CbGeAlD
Rifabutin—HSP90AA1—epithelium—ovarian cancer	0.0074	0.0266	CbGeAlD
Rifabutin—HSP90AA1—uterine cervix—ovarian cancer	0.00733	0.0264	CbGeAlD
Rifabutin—HSP90B1—bone marrow—ovarian cancer	0.00709	0.0255	CbGeAlD
Rifabutin—HSP90AA1—decidua—ovarian cancer	0.00699	0.0251	CbGeAlD
Rifabutin—HSP90B1—female gonad—ovarian cancer	0.00684	0.0246	CbGeAlD
Rifabutin—HSP90B1—vagina—ovarian cancer	0.0068	0.0244	CbGeAlD
Rifabutin—HSP90AA1—endometrium—ovarian cancer	0.00663	0.0239	CbGeAlD
Rifabutin—CYP3A4—Docetaxel—ovarian cancer	0.00648	0.127	CbGbCtD
Rifabutin—HSP90AA1—gonad—ovarian cancer	0.00615	0.0221	CbGeAlD
Rifabutin—HSP90AA1—uterus—ovarian cancer	0.00611	0.022	CbGeAlD
Rifabutin—HSP90B1—testis—ovarian cancer	0.00606	0.0218	CbGeAlD
Rifabutin—HSP90AA1—female reproductive system—ovarian cancer	0.00549	0.0198	CbGeAlD
Rifabutin—HSP90AA1—bone marrow—ovarian cancer	0.00519	0.0187	CbGeAlD
Rifabutin—HSP90AA1—female gonad—ovarian cancer	0.005	0.018	CbGeAlD
Rifabutin—HSP90AA1—vagina—ovarian cancer	0.00497	0.0179	CbGeAlD
Rifabutin—CYP3A4—Doxorubicin—ovarian cancer	0.00483	0.0945	CbGbCtD
Rifabutin—HSP90AA1—testis—ovarian cancer	0.00443	0.016	CbGeAlD
Rifabutin—HSP90B1—lymph node—ovarian cancer	0.0044	0.0158	CbGeAlD
Rifabutin—HSP90AA1—lymph node—ovarian cancer	0.00321	0.0116	CbGeAlD
Rifabutin—CYP3A4—female reproductive system—ovarian cancer	0.00129	0.00463	CbGeAlD
Rifabutin—Aspartate aminotransferase increased—Docetaxel—ovarian cancer	0.000885	0.00266	CcSEcCtD
Rifabutin—Chest pain—Vinorelbine—ovarian cancer	0.000883	0.00266	CcSEcCtD
Rifabutin—Arthralgia—Vinorelbine—ovarian cancer	0.000883	0.00266	CcSEcCtD
Rifabutin—Myalgia—Vinorelbine—ovarian cancer	0.000883	0.00266	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Melphalan—ovarian cancer	0.000883	0.00266	CcSEcCtD
Rifabutin—Dyspnoea—Topotecan—ovarian cancer	0.000883	0.00266	CcSEcCtD
Rifabutin—Abdominal pain—Chlorambucil—ovarian cancer	0.000879	0.00265	CcSEcCtD
Rifabutin—Body temperature increased—Chlorambucil—ovarian cancer	0.000879	0.00265	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—ovarian cancer	0.000877	0.00264	CcSEcCtD
Rifabutin—Dyspepsia—Topotecan—ovarian cancer	0.000871	0.00262	CcSEcCtD
Rifabutin—Paraesthesia—Melphalan—ovarian cancer	0.00087	0.00262	CcSEcCtD
Rifabutin—Alanine aminotransferase increased—Docetaxel—ovarian cancer	0.000866	0.00261	CcSEcCtD
Rifabutin—Dyspnoea—Melphalan—ovarian cancer	0.000864	0.0026	CcSEcCtD
Rifabutin—Decreased appetite—Topotecan—ovarian cancer	0.000861	0.00259	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Topotecan—ovarian cancer	0.000855	0.00257	CcSEcCtD
Rifabutin—Dyspepsia—Melphalan—ovarian cancer	0.000853	0.00257	CcSEcCtD
Rifabutin—Pain—Topotecan—ovarian cancer	0.000847	0.00255	CcSEcCtD
Rifabutin—Hepatobiliary disease—Paclitaxel—ovarian cancer	0.000845	0.00254	CcSEcCtD
Rifabutin—Phosphatase alkaline increased—Doxorubicin—ovarian cancer	0.000845	0.00254	CcSEcCtD
Rifabutin—Decreased appetite—Melphalan—ovarian cancer	0.000843	0.00254	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Melphalan—ovarian cancer	0.000837	0.00252	CcSEcCtD
Rifabutin—Bronchospasm—Docetaxel—ovarian cancer	0.000835	0.00251	CcSEcCtD
Rifabutin—Eructation—Doxorubicin—ovarian cancer	0.00083	0.0025	CcSEcCtD
Rifabutin—Thrombocytopenia—Vinorelbine—ovarian cancer	0.000829	0.0025	CcSEcCtD
Rifabutin—Pain—Melphalan—ovarian cancer	0.000829	0.0025	CcSEcCtD
Rifabutin—Skin disorder—Vinorelbine—ovarian cancer	0.000823	0.00248	CcSEcCtD
Rifabutin—Hypersensitivity—Chlorambucil—ovarian cancer	0.000819	0.00247	CcSEcCtD
Rifabutin—Feeling abnormal—Topotecan—ovarian cancer	0.000816	0.00246	CcSEcCtD
Rifabutin—Gastrointestinal pain—Topotecan—ovarian cancer	0.00081	0.00244	CcSEcCtD
Rifabutin—Anorexia—Vinorelbine—ovarian cancer	0.000807	0.00243	CcSEcCtD
Rifabutin—Pancytopenia—Docetaxel—ovarian cancer	0.000806	0.00243	CcSEcCtD
Rifabutin—Asthenia—Chlorambucil—ovarian cancer	0.000798	0.0024	CcSEcCtD
Rifabutin—Neutropenia—Docetaxel—ovarian cancer	0.000794	0.00239	CcSEcCtD
Rifabutin—Connective tissue disorder—Paclitaxel—ovarian cancer	0.000788	0.00237	CcSEcCtD
Rifabutin—Pruritus—Chlorambucil—ovarian cancer	0.000787	0.00237	CcSEcCtD
Rifabutin—Abdominal pain—Topotecan—ovarian cancer	0.000783	0.00236	CcSEcCtD
Rifabutin—Body temperature increased—Topotecan—ovarian cancer	0.000783	0.00236	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.000772	0.00232	CcSEcCtD
Rifabutin—Blood alkaline phosphatase increased—Epirubicin—ovarian cancer	0.000762	0.00229	CcSEcCtD
Rifabutin—Diarrhoea—Chlorambucil—ovarian cancer	0.000761	0.00229	CcSEcCtD
Rifabutin—Paraesthesia—Vinorelbine—ovarian cancer	0.00076	0.00229	CcSEcCtD
Rifabutin—Dyspnoea—Vinorelbine—ovarian cancer	0.000755	0.00227	CcSEcCtD
Rifabutin—Eye disorder—Paclitaxel—ovarian cancer	0.000749	0.00226	CcSEcCtD
Rifabutin—Jaundice—Docetaxel—ovarian cancer	0.000738	0.00222	CcSEcCtD
Rifabutin—Decreased appetite—Vinorelbine—ovarian cancer	0.000736	0.00222	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.000731	0.0022	CcSEcCtD
Rifabutin—Hypersensitivity—Topotecan—ovarian cancer	0.000729	0.0022	CcSEcCtD
Rifabutin—Pain—Vinorelbine—ovarian cancer	0.000724	0.00218	CcSEcCtD
Rifabutin—Immune system disorder—Paclitaxel—ovarian cancer	0.000724	0.00218	CcSEcCtD
Rifabutin—Hepatobiliary disease—Docetaxel—ovarian cancer	0.000716	0.00216	CcSEcCtD
Rifabutin—Hypersensitivity—Melphalan—ovarian cancer	0.000714	0.00215	CcSEcCtD
Rifabutin—Asthenia—Topotecan—ovarian cancer	0.00071	0.00214	CcSEcCtD
Rifabutin—Vomiting—Chlorambucil—ovarian cancer	0.000707	0.00213	CcSEcCtD
Rifabutin—Agranulocytosis—Docetaxel—ovarian cancer	0.000707	0.00213	CcSEcCtD
Rifabutin—Blood alkaline phosphatase increased—Doxorubicin—ovarian cancer	0.000705	0.00212	CcSEcCtD
Rifabutin—Pruritus—Topotecan—ovarian cancer	0.0007	0.00211	CcSEcCtD
Rifabutin—Feeling abnormal—Vinorelbine—ovarian cancer	0.000698	0.0021	CcSEcCtD
Rifabutin—Asthenia—Melphalan—ovarian cancer	0.000696	0.00209	CcSEcCtD
Rifabutin—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.000693	0.00208	CcSEcCtD
Rifabutin—Flatulence—Paclitaxel—ovarian cancer	0.000688	0.00207	CcSEcCtD
Rifabutin—Pruritus—Melphalan—ovarian cancer	0.000686	0.00206	CcSEcCtD
Rifabutin—Dysgeusia—Paclitaxel—ovarian cancer	0.000684	0.00206	CcSEcCtD
Rifabutin—Hepatitis—Docetaxel—ovarian cancer	0.00068	0.00205	CcSEcCtD
Rifabutin—Diarrhoea—Topotecan—ovarian cancer	0.000677	0.00204	CcSEcCtD
Rifabutin—Abdominal pain—Vinorelbine—ovarian cancer	0.00067	0.00202	CcSEcCtD
Rifabutin—Body temperature increased—Vinorelbine—ovarian cancer	0.00067	0.00202	CcSEcCtD
Rifabutin—Connective tissue disorder—Docetaxel—ovarian cancer	0.000668	0.00201	CcSEcCtD
Rifabutin—Diarrhoea—Melphalan—ovarian cancer	0.000663	0.002	CcSEcCtD
Rifabutin—Nausea—Chlorambucil—ovarian cancer	0.000661	0.00199	CcSEcCtD
Rifabutin—Anaemia—Paclitaxel—ovarian cancer	0.000645	0.00194	CcSEcCtD
Rifabutin—Eye disorder—Docetaxel—ovarian cancer	0.000635	0.00191	CcSEcCtD
Rifabutin—Vomiting—Topotecan—ovarian cancer	0.000629	0.00189	CcSEcCtD
Rifabutin—Leukopenia—Paclitaxel—ovarian cancer	0.000625	0.00188	CcSEcCtD
Rifabutin—Rash—Topotecan—ovarian cancer	0.000624	0.00188	CcSEcCtD
Rifabutin—Hypersensitivity—Vinorelbine—ovarian cancer	0.000624	0.00188	CcSEcCtD
Rifabutin—Dermatitis—Topotecan—ovarian cancer	0.000624	0.00188	CcSEcCtD
Rifabutin—Headache—Topotecan—ovarian cancer	0.00062	0.00187	CcSEcCtD
Rifabutin—Vomiting—Melphalan—ovarian cancer	0.000616	0.00186	CcSEcCtD
Rifabutin—Immune system disorder—Docetaxel—ovarian cancer	0.000614	0.00185	CcSEcCtD
Rifabutin—Rash—Melphalan—ovarian cancer	0.000611	0.00184	CcSEcCtD
Rifabutin—Dermatitis—Melphalan—ovarian cancer	0.000611	0.00184	CcSEcCtD
Rifabutin—Asthenia—Vinorelbine—ovarian cancer	0.000608	0.00183	CcSEcCtD
Rifabutin—Convulsion—Paclitaxel—ovarian cancer	0.000605	0.00182	CcSEcCtD
Rifabutin—Pruritus—Vinorelbine—ovarian cancer	0.000599	0.0018	CcSEcCtD
Rifabutin—Aspartate aminotransferase increased—Epirubicin—ovarian cancer	0.000597	0.0018	CcSEcCtD
Rifabutin—Myalgia—Paclitaxel—ovarian cancer	0.000594	0.00179	CcSEcCtD
Rifabutin—Chest pain—Paclitaxel—ovarian cancer	0.000594	0.00179	CcSEcCtD
Rifabutin—Arthralgia—Paclitaxel—ovarian cancer	0.000594	0.00179	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.00059	0.00178	CcSEcCtD
Rifabutin—Nausea—Topotecan—ovarian cancer	0.000588	0.00177	CcSEcCtD
Rifabutin—Alanine aminotransferase increased—Epirubicin—ovarian cancer	0.000584	0.00176	CcSEcCtD
Rifabutin—Diarrhoea—Vinorelbine—ovarian cancer	0.000579	0.00174	CcSEcCtD
Rifabutin—Dysgeusia—Docetaxel—ovarian cancer	0.000579	0.00174	CcSEcCtD
Rifabutin—Nausea—Melphalan—ovarian cancer	0.000576	0.00173	CcSEcCtD
Rifabutin—Confusional state—Paclitaxel—ovarian cancer	0.000574	0.00173	CcSEcCtD
Rifabutin—Eosinophilia—Epirubicin—ovarian cancer	0.000567	0.00171	CcSEcCtD
Rifabutin—Shock—Paclitaxel—ovarian cancer	0.00056	0.00169	CcSEcCtD
Rifabutin—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000558	0.00168	CcSEcCtD
Rifabutin—Skin disorder—Paclitaxel—ovarian cancer	0.000553	0.00167	CcSEcCtD
Rifabutin—Aspartate aminotransferase increased—Doxorubicin—ovarian cancer	0.000552	0.00166	CcSEcCtD
Rifabutin—Anaemia—Docetaxel—ovarian cancer	0.000547	0.00165	CcSEcCtD
Rifabutin—Pancytopenia—Epirubicin—ovarian cancer	0.000544	0.00164	CcSEcCtD
Rifabutin—Anorexia—Paclitaxel—ovarian cancer	0.000543	0.00163	CcSEcCtD
Rifabutin—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	0.000541	0.00163	CcSEcCtD
Rifabutin—Vomiting—Vinorelbine—ovarian cancer	0.000538	0.00162	CcSEcCtD
Rifabutin—Neutropenia—Epirubicin—ovarian cancer	0.000536	0.00161	CcSEcCtD
Rifabutin—Rash—Vinorelbine—ovarian cancer	0.000534	0.00161	CcSEcCtD
Rifabutin—Dermatitis—Vinorelbine—ovarian cancer	0.000534	0.00161	CcSEcCtD
Rifabutin—Headache—Vinorelbine—ovarian cancer	0.000531	0.0016	CcSEcCtD
Rifabutin—Leukopenia—Docetaxel—ovarian cancer	0.00053	0.00159	CcSEcCtD
Rifabutin—Eosinophilia—Doxorubicin—ovarian cancer	0.000525	0.00158	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000519	0.00156	CcSEcCtD
Rifabutin—Insomnia—Paclitaxel—ovarian cancer	0.000515	0.00155	CcSEcCtD
Rifabutin—Convulsion—Docetaxel—ovarian cancer	0.000513	0.00154	CcSEcCtD
Rifabutin—Paraesthesia—Paclitaxel—ovarian cancer	0.000512	0.00154	CcSEcCtD
Rifabutin—Dyspnoea—Paclitaxel—ovarian cancer	0.000508	0.00153	CcSEcCtD
Rifabutin—Arthralgia—Docetaxel—ovarian cancer	0.000504	0.00152	CcSEcCtD
Rifabutin—Chest pain—Docetaxel—ovarian cancer	0.000504	0.00152	CcSEcCtD
Rifabutin—Myalgia—Docetaxel—ovarian cancer	0.000504	0.00152	CcSEcCtD
Rifabutin—Pancytopenia—Doxorubicin—ovarian cancer	0.000503	0.00151	CcSEcCtD
Rifabutin—Nausea—Vinorelbine—ovarian cancer	0.000503	0.00151	CcSEcCtD
Rifabutin—Dyspepsia—Paclitaxel—ovarian cancer	0.000501	0.00151	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.0005	0.00151	CcSEcCtD
Rifabutin—Jaundice—Epirubicin—ovarian cancer	0.000498	0.0015	CcSEcCtD
Rifabutin—Neutropenia—Doxorubicin—ovarian cancer	0.000496	0.00149	CcSEcCtD
Rifabutin—Decreased appetite—Paclitaxel—ovarian cancer	0.000495	0.00149	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000492	0.00148	CcSEcCtD
Rifabutin—Pain—Paclitaxel—ovarian cancer	0.000487	0.00147	CcSEcCtD
Rifabutin—Confusional state—Docetaxel—ovarian cancer	0.000487	0.00147	CcSEcCtD
Rifabutin—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000483	0.00145	CcSEcCtD
Rifabutin—Agranulocytosis—Epirubicin—ovarian cancer	0.000477	0.00143	CcSEcCtD
Rifabutin—Shock—Docetaxel—ovarian cancer	0.000475	0.00143	CcSEcCtD
Rifabutin—Thrombocytopenia—Docetaxel—ovarian cancer	0.000473	0.00142	CcSEcCtD
Rifabutin—Feeling abnormal—Paclitaxel—ovarian cancer	0.000469	0.00141	CcSEcCtD
Rifabutin—Skin disorder—Docetaxel—ovarian cancer	0.000469	0.00141	CcSEcCtD
Rifabutin—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000466	0.0014	CcSEcCtD
Rifabutin—Jaundice—Doxorubicin—ovarian cancer	0.000461	0.00139	CcSEcCtD
Rifabutin—Anorexia—Docetaxel—ovarian cancer	0.00046	0.00139	CcSEcCtD
Rifabutin—Hepatitis—Epirubicin—ovarian cancer	0.000458	0.00138	CcSEcCtD
Rifabutin—Connective tissue disorder—Epirubicin—ovarian cancer	0.00045	0.00136	CcSEcCtD
Rifabutin—Abdominal pain—Paclitaxel—ovarian cancer	0.00045	0.00136	CcSEcCtD
Rifabutin—Body temperature increased—Paclitaxel—ovarian cancer	0.00045	0.00136	CcSEcCtD
Rifabutin—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000447	0.00135	CcSEcCtD
Rifabutin—Agranulocytosis—Doxorubicin—ovarian cancer	0.000441	0.00133	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.00044	0.00132	CcSEcCtD
Rifabutin—Insomnia—Docetaxel—ovarian cancer	0.000437	0.00131	CcSEcCtD
Rifabutin—Paraesthesia—Docetaxel—ovarian cancer	0.000434	0.00131	CcSEcCtD
Rifabutin—Dyspnoea—Docetaxel—ovarian cancer	0.00043	0.0013	CcSEcCtD
Rifabutin—Eye disorder—Epirubicin—ovarian cancer	0.000428	0.00129	CcSEcCtD
Rifabutin—Dyspepsia—Docetaxel—ovarian cancer	0.000425	0.00128	CcSEcCtD
Rifabutin—Hepatitis—Doxorubicin—ovarian cancer	0.000424	0.00128	CcSEcCtD
Rifabutin—Decreased appetite—Docetaxel—ovarian cancer	0.00042	0.00126	CcSEcCtD
Rifabutin—Hypersensitivity—Paclitaxel—ovarian cancer	0.00042	0.00126	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000417	0.00125	CcSEcCtD
Rifabutin—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000417	0.00125	CcSEcCtD
Rifabutin—Immune system disorder—Epirubicin—ovarian cancer	0.000414	0.00125	CcSEcCtD
Rifabutin—Pain—Docetaxel—ovarian cancer	0.000413	0.00124	CcSEcCtD
Rifabutin—Asthenia—Paclitaxel—ovarian cancer	0.000409	0.00123	CcSEcCtD
Rifabutin—Pruritus—Paclitaxel—ovarian cancer	0.000403	0.00121	CcSEcCtD
Rifabutin—Feeling abnormal—Docetaxel—ovarian cancer	0.000398	0.0012	CcSEcCtD
Rifabutin—Eye disorder—Doxorubicin—ovarian cancer	0.000396	0.00119	CcSEcCtD
Rifabutin—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000395	0.00119	CcSEcCtD
Rifabutin—Flatulence—Epirubicin—ovarian cancer	0.000393	0.00118	CcSEcCtD
Rifabutin—Dysgeusia—Epirubicin—ovarian cancer	0.000391	0.00118	CcSEcCtD
Rifabutin—Diarrhoea—Paclitaxel—ovarian cancer	0.00039	0.00117	CcSEcCtD
Rifabutin—Immune system disorder—Doxorubicin—ovarian cancer	0.000383	0.00115	CcSEcCtD
Rifabutin—Abdominal pain—Docetaxel—ovarian cancer	0.000382	0.00115	CcSEcCtD
Rifabutin—Body temperature increased—Docetaxel—ovarian cancer	0.000382	0.00115	CcSEcCtD
Rifabutin—Anaemia—Epirubicin—ovarian cancer	0.000369	0.00111	CcSEcCtD
Rifabutin—Flatulence—Doxorubicin—ovarian cancer	0.000364	0.0011	CcSEcCtD
Rifabutin—Vomiting—Paclitaxel—ovarian cancer	0.000362	0.00109	CcSEcCtD
Rifabutin—Dysgeusia—Doxorubicin—ovarian cancer	0.000362	0.00109	CcSEcCtD
Rifabutin—Rash—Paclitaxel—ovarian cancer	0.000359	0.00108	CcSEcCtD
Rifabutin—Dermatitis—Paclitaxel—ovarian cancer	0.000359	0.00108	CcSEcCtD
Rifabutin—Leukopenia—Epirubicin—ovarian cancer	0.000357	0.00108	CcSEcCtD
Rifabutin—Headache—Paclitaxel—ovarian cancer	0.000357	0.00107	CcSEcCtD
Rifabutin—Hypersensitivity—Docetaxel—ovarian cancer	0.000356	0.00107	CcSEcCtD
Rifabutin—Asthenia—Docetaxel—ovarian cancer	0.000346	0.00104	CcSEcCtD
Rifabutin—Convulsion—Epirubicin—ovarian cancer	0.000346	0.00104	CcSEcCtD
Rifabutin—Pruritus—Docetaxel—ovarian cancer	0.000342	0.00103	CcSEcCtD
Rifabutin—Anaemia—Doxorubicin—ovarian cancer	0.000341	0.00103	CcSEcCtD
Rifabutin—Arthralgia—Epirubicin—ovarian cancer	0.00034	0.00102	CcSEcCtD
Rifabutin—Myalgia—Epirubicin—ovarian cancer	0.00034	0.00102	CcSEcCtD
Rifabutin—Chest pain—Epirubicin—ovarian cancer	0.00034	0.00102	CcSEcCtD
Rifabutin—Nausea—Paclitaxel—ovarian cancer	0.000338	0.00102	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000337	0.00102	CcSEcCtD
Rifabutin—Leukopenia—Doxorubicin—ovarian cancer	0.000331	0.000995	CcSEcCtD
Rifabutin—Diarrhoea—Docetaxel—ovarian cancer	0.00033	0.000994	CcSEcCtD
Rifabutin—Confusional state—Epirubicin—ovarian cancer	0.000328	0.000988	CcSEcCtD
Rifabutin—Shock—Epirubicin—ovarian cancer	0.00032	0.000964	CcSEcCtD
Rifabutin—Convulsion—Doxorubicin—ovarian cancer	0.00032	0.000963	CcSEcCtD
Rifabutin—Thrombocytopenia—Epirubicin—ovarian cancer	0.000319	0.00096	CcSEcCtD
Rifabutin—Skin disorder—Epirubicin—ovarian cancer	0.000316	0.000952	CcSEcCtD
Rifabutin—Chest pain—Doxorubicin—ovarian cancer	0.000314	0.000946	CcSEcCtD
Rifabutin—Arthralgia—Doxorubicin—ovarian cancer	0.000314	0.000946	CcSEcCtD
Rifabutin—Myalgia—Doxorubicin—ovarian cancer	0.000314	0.000946	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000312	0.00094	CcSEcCtD
Rifabutin—Anorexia—Epirubicin—ovarian cancer	0.00031	0.000934	CcSEcCtD
Rifabutin—Vomiting—Docetaxel—ovarian cancer	0.000307	0.000924	CcSEcCtD
Rifabutin—Rash—Docetaxel—ovarian cancer	0.000304	0.000916	CcSEcCtD
Rifabutin—Dermatitis—Docetaxel—ovarian cancer	0.000304	0.000916	CcSEcCtD
Rifabutin—Confusional state—Doxorubicin—ovarian cancer	0.000304	0.000915	CcSEcCtD
Rifabutin—Headache—Docetaxel—ovarian cancer	0.000302	0.00091	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000297	0.000893	CcSEcCtD
Rifabutin—Shock—Doxorubicin—ovarian cancer	0.000296	0.000892	CcSEcCtD
Rifabutin—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000295	0.000888	CcSEcCtD
Rifabutin—Insomnia—Epirubicin—ovarian cancer	0.000295	0.000887	CcSEcCtD
Rifabutin—Skin disorder—Doxorubicin—ovarian cancer	0.000293	0.000881	CcSEcCtD
Rifabutin—Paraesthesia—Epirubicin—ovarian cancer	0.000292	0.00088	CcSEcCtD
Rifabutin—Dyspnoea—Epirubicin—ovarian cancer	0.00029	0.000874	CcSEcCtD
Rifabutin—Anorexia—Doxorubicin—ovarian cancer	0.000287	0.000865	CcSEcCtD
Rifabutin—Nausea—Docetaxel—ovarian cancer	0.000287	0.000863	CcSEcCtD
Rifabutin—Dyspepsia—Epirubicin—ovarian cancer	0.000287	0.000863	CcSEcCtD
Rifabutin—Decreased appetite—Epirubicin—ovarian cancer	0.000283	0.000852	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000281	0.000846	CcSEcCtD
Rifabutin—Pain—Epirubicin—ovarian cancer	0.000279	0.000838	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000275	0.000826	CcSEcCtD
Rifabutin—Insomnia—Doxorubicin—ovarian cancer	0.000273	0.00082	CcSEcCtD
Rifabutin—Paraesthesia—Doxorubicin—ovarian cancer	0.000271	0.000814	CcSEcCtD
Rifabutin—Dyspnoea—Doxorubicin—ovarian cancer	0.000269	0.000809	CcSEcCtD
Rifabutin—Feeling abnormal—Epirubicin—ovarian cancer	0.000268	0.000808	CcSEcCtD
Rifabutin—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000266	0.000802	CcSEcCtD
Rifabutin—Dyspepsia—Doxorubicin—ovarian cancer	0.000265	0.000798	CcSEcCtD
Rifabutin—Decreased appetite—Doxorubicin—ovarian cancer	0.000262	0.000788	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.00026	0.000783	CcSEcCtD
Rifabutin—Pain—Doxorubicin—ovarian cancer	0.000258	0.000776	CcSEcCtD
Rifabutin—Abdominal pain—Epirubicin—ovarian cancer	0.000257	0.000775	CcSEcCtD
Rifabutin—Body temperature increased—Epirubicin—ovarian cancer	0.000257	0.000775	CcSEcCtD
Rifabutin—Feeling abnormal—Doxorubicin—ovarian cancer	0.000248	0.000747	CcSEcCtD
Rifabutin—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000246	0.000742	CcSEcCtD
Rifabutin—Hypersensitivity—Epirubicin—ovarian cancer	0.00024	0.000722	CcSEcCtD
Rifabutin—Body temperature increased—Doxorubicin—ovarian cancer	0.000238	0.000717	CcSEcCtD
Rifabutin—Abdominal pain—Doxorubicin—ovarian cancer	0.000238	0.000717	CcSEcCtD
Rifabutin—Asthenia—Epirubicin—ovarian cancer	0.000234	0.000703	CcSEcCtD
Rifabutin—Pruritus—Epirubicin—ovarian cancer	0.00023	0.000694	CcSEcCtD
Rifabutin—Diarrhoea—Epirubicin—ovarian cancer	0.000223	0.000671	CcSEcCtD
Rifabutin—Hypersensitivity—Doxorubicin—ovarian cancer	0.000222	0.000668	CcSEcCtD
Rifabutin—Asthenia—Doxorubicin—ovarian cancer	0.000216	0.000651	CcSEcCtD
Rifabutin—Pruritus—Doxorubicin—ovarian cancer	0.000213	0.000642	CcSEcCtD
Rifabutin—Vomiting—Epirubicin—ovarian cancer	0.000207	0.000623	CcSEcCtD
Rifabutin—Diarrhoea—Doxorubicin—ovarian cancer	0.000206	0.000621	CcSEcCtD
Rifabutin—Rash—Epirubicin—ovarian cancer	0.000205	0.000618	CcSEcCtD
Rifabutin—Dermatitis—Epirubicin—ovarian cancer	0.000205	0.000618	CcSEcCtD
Rifabutin—Headache—Epirubicin—ovarian cancer	0.000204	0.000614	CcSEcCtD
Rifabutin—Nausea—Epirubicin—ovarian cancer	0.000193	0.000582	CcSEcCtD
Rifabutin—Vomiting—Doxorubicin—ovarian cancer	0.000192	0.000577	CcSEcCtD
Rifabutin—HSP90B1—Immune System—ERBB2—ovarian cancer	0.000191	0.000563	CbGpPWpGaD
Rifabutin—Rash—Doxorubicin—ovarian cancer	0.00019	0.000572	CcSEcCtD
Rifabutin—Dermatitis—Doxorubicin—ovarian cancer	0.00019	0.000571	CcSEcCtD
Rifabutin—Headache—Doxorubicin—ovarian cancer	0.000189	0.000568	CcSEcCtD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ovarian cancer	0.000188	0.000556	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—ovarian cancer	0.000188	0.000556	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—PIK3CB—ovarian cancer	0.000188	0.000556	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—MTOR—ovarian cancer	0.000188	0.000556	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by ERBB2—IL6—ovarian cancer	0.000187	0.000553	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—EREG—ovarian cancer	0.000187	0.000553	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—ovarian cancer	0.000184	0.000544	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—VEGFA—ovarian cancer	0.000184	0.000543	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—HRAS—ovarian cancer	0.000182	0.000538	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—STAT3—ovarian cancer	0.000182	0.000538	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—HRAS—ovarian cancer	0.00018	0.000531	CbGpPWpGaD
Rifabutin—Nausea—Doxorubicin—ovarian cancer	0.000179	0.000539	CcSEcCtD
Rifabutin—HSP90AA1—Innate Immune System—TLR4—ovarian cancer	0.000179	0.000528	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—CDKN1B—ovarian cancer	0.000177	0.000522	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—IL6—ovarian cancer	0.000174	0.000515	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—MAPK3—ovarian cancer	0.000174	0.000514	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—MMP9—ovarian cancer	0.000174	0.000514	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—IL2—ovarian cancer	0.000173	0.00051	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by ERBB2—AKT1—ovarian cancer	0.000173	0.00051	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—IL6—ovarian cancer	0.000172	0.000508	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—IL6ST—ovarian cancer	0.000171	0.000506	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—YAP1—ovarian cancer	0.000168	0.000497	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—CTNNB1—ovarian cancer	0.000167	0.000493	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—MAPK1—ovarian cancer	0.000166	0.000489	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—MMP2—ovarian cancer	0.000165	0.000488	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—FASN—ovarian cancer	0.000164	0.000484	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PARP1—ovarian cancer	0.000163	0.000482	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—PTEN—ovarian cancer	0.000163	0.00048	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—AKT1—ovarian cancer	0.000161	0.000475	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—HDAC6—ovarian cancer	0.000159	0.000469	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—AKT1—ovarian cancer	0.000159	0.000469	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—ovarian cancer	0.000157	0.000463	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—VEGFA—ovarian cancer	0.000156	0.000461	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—SLC2A1—ovarian cancer	0.000156	0.000459	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—ovarian cancer	0.000155	0.000457	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—NRAS—ovarian cancer	0.000154	0.000456	CbGpPWpGaD
Rifabutin—CYP1A2—Biological oxidations—CYP1B1—ovarian cancer	0.000154	0.000454	CbGpPWpGaD
Rifabutin—CYP1A2—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000152	0.000447	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—MAPK3—ovarian cancer	0.000148	0.000436	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—STAT3—ovarian cancer	0.000145	0.000429	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—NRAS—ovarian cancer	0.000145	0.000428	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—ERBB2—ovarian cancer	0.000145	0.000427	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—PIK3CD—ovarian cancer	0.000145	0.000427	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—ovarian cancer	0.000144	0.000426	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—PPP2R1A—ovarian cancer	0.000143	0.000423	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—ovarian cancer	0.000141	0.000416	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—ovarian cancer	0.000141	0.000416	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—ovarian cancer	0.000141	0.000416	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—YAP1—ovarian cancer	0.000141	0.000415	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—MAPK1—ovarian cancer	0.000141	0.000415	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—EGFR—ovarian cancer	0.000141	0.000415	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—TP53—ovarian cancer	0.000139	0.000411	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—MAPK3—ovarian cancer	0.000139	0.00041	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—CDKN1B—ovarian cancer	0.000139	0.00041	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—XIAP—ovarian cancer	0.000138	0.000407	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—FASN—ovarian cancer	0.000137	0.000405	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—SLC5A5—ovarian cancer	0.000135	0.000398	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—SMARCA4—ovarian cancer	0.000134	0.000397	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—ovarian cancer	0.000133	0.000393	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—KRAS—ovarian cancer	0.000133	0.000392	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—CCND1—ovarian cancer	0.000132	0.000391	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PPP2R1A—ovarian cancer	0.000132	0.000391	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—MAPK1—ovarian cancer	0.000132	0.00039	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—EGFR—ovarian cancer	0.000132	0.00039	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—EREG—ovarian cancer	0.000131	0.000387	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—SLC2A1—ovarian cancer	0.00013	0.000385	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—ERBB2—ovarian cancer	0.000128	0.000377	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CD8A—ovarian cancer	0.000128	0.000377	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—IL6—ovarian cancer	0.000127	0.000376	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—CTNNB1—ovarian cancer	0.000127	0.000374	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—MTOR—ovarian cancer	0.000126	0.000373	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—PIK3CB—ovarian cancer	0.000126	0.000373	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—CYP1B1—ovarian cancer	0.000125	0.000369	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—KRAS—ovarian cancer	0.000125	0.000369	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—MMP9—ovarian cancer	0.000124	0.000367	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—CDKN1B—ovarian cancer	0.000124	0.000366	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PGR—ovarian cancer	0.000123	0.000363	CbGpPWpGaD
Rifabutin—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	0.000119	0.00035	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.000118	0.00035	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—CCND1—ovarian cancer	0.000118	0.00035	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—CDKN1B—ovarian cancer	0.000118	0.00035	CbGpPWpGaD
Rifabutin—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000117	0.000345	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—PIK3CA—ovarian cancer	0.000115	0.000339	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PARP1—ovarian cancer	0.000114	0.000337	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—ovarian cancer	0.000113	0.000334	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—HRAS—ovarian cancer	0.000113	0.000333	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—CTNNB1—ovarian cancer	0.000112	0.00033	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—VEGFA—ovarian cancer	0.000111	0.000329	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PPP2R1A—ovarian cancer	0.000111	0.000327	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—STAT3—ovarian cancer	0.00011	0.000326	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—NRAS—ovarian cancer	0.00011	0.000325	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—MAPK3—ovarian cancer	0.000109	0.000322	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—PTEN—ovarian cancer	0.000109	0.000322	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—IL6—ovarian cancer	0.000108	0.000319	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—MYC—ovarian cancer	0.000106	0.000314	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—HRAS—ovarian cancer	0.000106	0.000313	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—MAPK3—ovarian cancer	0.000105	0.000311	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—TERT—ovarian cancer	0.000105	0.00031	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—TLR4—ovarian cancer	0.000104	0.000307	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—MAPK1—ovarian cancer	0.000104	0.000307	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—ABCB1—ovarian cancer	0.000103	0.000304	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—IL6—ovarian cancer	0.000102	0.0003	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—TYMS—ovarian cancer	0.000101	0.000298	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—MAPK1—ovarian cancer	0.0001	0.000296	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—EGFR—ovarian cancer	0.0001	0.000296	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—IL6ST—ovarian cancer	9.98e-05	0.000295	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—MAPK3—ovarian cancer	9.76e-05	0.000288	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—NRAS—ovarian cancer	9.73e-05	0.000287	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—CAV1—ovarian cancer	9.72e-05	0.000287	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—MYC—ovarian cancer	9.5e-05	0.00028	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—KRAS—ovarian cancer	9.48e-05	0.00028	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—AKT1—ovarian cancer	9.37e-05	0.000277	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—NME2—ovarian cancer	9.37e-05	0.000277	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—MAPK3—ovarian cancer	9.32e-05	0.000275	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—MAPK1—ovarian cancer	9.29e-05	0.000274	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PPP2R1A—ovarian cancer	9.26e-05	0.000274	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—IL6ST—ovarian cancer	9.21e-05	0.000272	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—MAPK1—ovarian cancer	8.86e-05	0.000262	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—EGFR—ovarian cancer	8.86e-05	0.000262	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—APC—ovarian cancer	8.85e-05	0.000261	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CDH1—ovarian cancer	8.83e-05	0.000261	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—PIK3CD—ovarian cancer	8.43e-05	0.000249	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—KRAS—ovarian cancer	8.37e-05	0.000247	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—CAV1—ovarian cancer	8.14e-05	0.00024	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—HRAS—ovarian cancer	8.06e-05	0.000238	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	7.95e-05	0.000235	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—TP53—ovarian cancer	7.8e-05	0.00023	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PIK3CD—ovarian cancer	7.78e-05	0.00023	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—IL6—ovarian cancer	7.71e-05	0.000228	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—PIK3CA—ovarian cancer	7.69e-05	0.000227	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—ERBB2—ovarian cancer	7.45e-05	0.00022	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PIK3CG—ovarian cancer	7.42e-05	0.000219	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—TERT—ovarian cancer	7.36e-05	0.000217	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—MTOR—ovarian cancer	7.35e-05	0.000217	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—PIK3CB—ovarian cancer	7.35e-05	0.000217	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—NME2—ovarian cancer	7.23e-05	0.000213	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—HRAS—ovarian cancer	7.12e-05	0.00021	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—AKT1—ovarian cancer	7.11e-05	0.00021	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CDKN1B—ovarian cancer	6.9e-05	0.000204	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—ERBB2—ovarian cancer	6.87e-05	0.000203	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—IL6—ovarian cancer	6.81e-05	0.000201	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CAV1—ovarian cancer	6.81e-05	0.000201	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—MTOR—ovarian cancer	6.78e-05	0.0002	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PIK3CB—ovarian cancer	6.78e-05	0.0002	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—IL2—ovarian cancer	6.75e-05	0.000199	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—ESR1—ovarian cancer	6.56e-05	0.000194	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PIK3CD—ovarian cancer	6.52e-05	0.000192	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CTNNB1—ovarian cancer	6.51e-05	0.000192	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	6.48e-05	0.000191	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—IL6ST—ovarian cancer	6.45e-05	0.000191	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—CDKN1B—ovarian cancer	6.37e-05	0.000188	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—PTEN—ovarian cancer	6.35e-05	0.000187	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—AKT1—ovarian cancer	6.28e-05	0.000186	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PIK3CG—ovarian cancer	6.2e-05	0.000183	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—APC—ovarian cancer	6.2e-05	0.000183	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CYTB—ovarian cancer	6.04e-05	0.000178	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—CTNNB1—ovarian cancer	6.01e-05	0.000178	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	5.9e-05	0.000174	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PTEN—ovarian cancer	5.86e-05	0.000173	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PIK3CB—ovarian cancer	5.68e-05	0.000168	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—STAT3—ovarian cancer	5.68e-05	0.000168	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—NRAS—ovarian cancer	5.67e-05	0.000167	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PIK3CD—ovarian cancer	5.45e-05	0.000161	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—MAPK3—ovarian cancer	5.43e-05	0.00016	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—BRIP1—ovarian cancer	5.28e-05	0.000156	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PPP1CC—ovarian cancer	5.28e-05	0.000156	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—STAT3—ovarian cancer	5.24e-05	0.000155	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—NRAS—ovarian cancer	5.23e-05	0.000154	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—MAPK1—ovarian cancer	5.16e-05	0.000152	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—EGFR—ovarian cancer	5.16e-05	0.000152	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—MAPK3—ovarian cancer	5.01e-05	0.000148	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PTEN—ovarian cancer	4.91e-05	0.000145	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—KRAS—ovarian cancer	4.88e-05	0.000144	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—MYC—ovarian cancer	4.87e-05	0.000144	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—ERBB2—ovarian cancer	4.81e-05	0.000142	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—MAPK1—ovarian cancer	4.77e-05	0.000141	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—EGFR—ovarian cancer	4.77e-05	0.000141	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MTOR—ovarian cancer	4.75e-05	0.00014	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PIK3CB—ovarian cancer	4.75e-05	0.00014	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CYTB—ovarian cancer	4.66e-05	0.000138	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CXCL8—ovarian cancer	4.57e-05	0.000135	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—KRAS—ovarian cancer	4.5e-05	0.000133	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—PIK3CA—ovarian cancer	4.48e-05	0.000132	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CDKN1B—ovarian cancer	4.46e-05	0.000132	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CASP3—ovarian cancer	4.37e-05	0.000129	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—IL2—ovarian cancer	4.36e-05	0.000129	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CCND1—ovarian cancer	4.25e-05	0.000126	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CTNNB1—ovarian cancer	4.21e-05	0.000124	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—HRAS—ovarian cancer	4.14e-05	0.000122	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PIK3CA—ovarian cancer	4.14e-05	0.000122	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MMP9—ovarian cancer	4.13e-05	0.000122	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PTEN—ovarian cancer	4.11e-05	0.000121	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PPP1CC—ovarian cancer	4.07e-05	0.00012	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—BRIP1—ovarian cancer	4.07e-05	0.00012	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—IL6—ovarian cancer	3.97e-05	0.000117	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	3.84e-05	0.000114	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—HRAS—ovarian cancer	3.83e-05	0.000113	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—VEGFA—ovarian cancer	3.71e-05	0.000109	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—STAT3—ovarian cancer	3.67e-05	0.000108	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—NRAS—ovarian cancer	3.66e-05	0.000108	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—IL6—ovarian cancer	3.66e-05	0.000108	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—AKT1—ovarian cancer	3.66e-05	0.000108	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—YAP1—ovarian cancer	3.54e-05	0.000104	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MAPK3—ovarian cancer	3.51e-05	0.000104	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	3.5e-05	0.000103	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PIK3CA—ovarian cancer	3.46e-05	0.000102	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MYC—ovarian cancer	3.41e-05	0.000101	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—AKT1—ovarian cancer	3.38e-05	9.98e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MAPK1—ovarian cancer	3.34e-05	9.85e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—EGFR—ovarian cancer	3.34e-05	9.85e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—KRAS—ovarian cancer	3.15e-05	9.31e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	3.08e-05	9.09e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PIK3CA—ovarian cancer	2.9e-05	8.55e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—FASN—ovarian cancer	2.88e-05	8.52e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—SLC5A5—ovarian cancer	2.84e-05	8.38e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—AKT1—ovarian cancer	2.83e-05	8.35e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—TP53—ovarian cancer	2.8e-05	8.27e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—SLC2A1—ovarian cancer	2.74e-05	8.09e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—YAP1—ovarian cancer	2.73e-05	8.06e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	2.68e-05	7.92e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—HRAS—ovarian cancer	2.68e-05	7.91e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CYP1B1—ovarian cancer	2.63e-05	7.76e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—IL6—ovarian cancer	2.56e-05	7.57e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—AKT1—ovarian cancer	2.37e-05	6.99e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	2.33e-05	6.88e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.32e-05	6.85e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—FASN—ovarian cancer	2.23e-05	6.57e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—SLC5A5—ovarian cancer	2.19e-05	6.47e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ABCB1—ovarian cancer	2.16e-05	6.39e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—TYMS—ovarian cancer	2.12e-05	6.27e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—SLC2A1—ovarian cancer	2.12e-05	6.24e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CYP1B1—ovarian cancer	2.03e-05	5.99e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	1.8e-05	5.31e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CAV1—ovarian cancer	1.71e-05	5.06e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ABCB1—ovarian cancer	1.67e-05	4.93e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—TYMS—ovarian cancer	1.64e-05	4.84e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.64e-05	4.83e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PIK3CG—ovarian cancer	1.56e-05	4.61e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PIK3CD—ovarian cancer	1.37e-05	4.05e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CAV1—ovarian cancer	1.32e-05	3.9e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PIK3CG—ovarian cancer	1.2e-05	3.55e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PIK3CB—ovarian cancer	1.2e-05	3.53e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PIK3CD—ovarian cancer	1.06e-05	3.12e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PTEN—ovarian cancer	1.03e-05	3.05e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PIK3CB—ovarian cancer	9.22e-06	2.72e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PTEN—ovarian cancer	7.97e-06	2.35e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PIK3CA—ovarian cancer	7.29e-06	2.15e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—AKT1—ovarian cancer	5.95e-06	1.76e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PIK3CA—ovarian cancer	5.62e-06	1.66e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—AKT1—ovarian cancer	4.59e-06	1.36e-05	CbGpPWpGaD
